Read the latest epilepsy news from Epilepsy Society.
Retigabine link to skin and eye problems
30 April 2013
US Food and Drug Administration (FDA) issues drug safety alert regarding the epilepsy medication Potiga also called ezogabine, which is known as Trobalt or retigabine...
Epilepsy Society's chief executive retires
12 April 2013
Epilepsy Society’s chief executive Graham Faulkner is standing down after more than a decade leading the UK's medical charity for people affected by epilepsy.
Drug trial for treatment of tuberous sclerosis
10 April 2013
A new trial is underway to see if a tumour-shrinking drug can improve the thought processes of adults with tuberous sclerosis, which can cause epilepsy.
Epilepsy gene discovery welcomed
9 April 2013
Professor Sanjay Sisodiya, Epilepsy Society’s head of genetics, welcomes the discovery of a gene associated with the most common form of epilepsy.
Concerns about benefits assessment
4 April 2013
A new report published by the Disability Benefits Consortium raises concerns about the delivery of the new Personal Independence Payment (PIP)assessment.
Hope for new epilepsy drugs
2 April 2013
Epilepsy expert Professor Ley Sander gives a cautious welcome to pioneering research which offers hope for the development of new epilepsy treatments.